EFFECT OF ZOLENDRONIC ACID IN TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

被引：0
|
作者：
Povoroznyuk, Vladyslav [1 ]
Grygorieva, Nataliia [1 ]
Vayda, Volodymyr [1 ]
Dzerovych, Nataliia [1 ]
Balatska, Nataliya [1 ]
机构：
[1] Ukraine Acad Med Sci, Inst Gerontol, Dept Clin Physiol & Pathol Locomotor Apparat, UA-252655 Kiev, Ukraine
来源：
BONE | 2010年 / 46卷
关键词：
D O I：
10.1016/j.bone.2010.01.062
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
59
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [21] Clodronic Acid in the Treatment of Postmenopausal Osteoporosis
    Refik Tanakol
    Sema Yarman
    Taner Bayraktaroglu
    Harika Boztepe
    Faruk Alagöl
    Clinical Drug Investigation, 2007, 27 : 419 - 433
  • [22] Clodronic acid in the treatment of postmenopausal osteoporosis
    Tanakol, Refik
    Yarman, Sema
    Bayraktaroglu, Taner
    Boztepe, Harika
    Alagol, Faruk
    CLINICAL DRUG INVESTIGATION, 2007, 27 (06) : 419 - 433
  • [23] Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
    Tucci, JR
    Tonino, RP
    Emkey, RD
    Peverly, CA
    Kher, U
    Santora, AC
    AMERICAN JOURNAL OF MEDICINE, 1996, 101 (05): : 488 - 501
  • [24] Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis
    McClung, Michael R.
    Boonen, Steven
    Torring, Ove
    Roux, Christian
    Rizzoli, Rene
    Bone, Henry G.
    Benhamou, Claude-Laurent
    Lems, Willem F.
    Minisola, Salvatore
    Halse, Johan
    Hoeck, Hans C.
    Eastell, Richard
    Wang, Andrea
    Siddhanti, Suresh
    Cummings, Steven R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (01) : 211 - 218
  • [25] The effect of alendronate treatment on urinary calcium exretion in women with postmenopausal osteoporosis
    Ochodnicky, M
    Ochodnická, E
    Galajda, P
    Vladar, L
    Mokáñ, M
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S191 - S192
  • [26] THE COMPARATIVE RESPONSE OF BIOCHEMICAL PARAMETERS CONCERNING TREATMENT WITH ZOLENDRONIC ACID 5MG A YEAR IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM AND POSTMENOPAUSAL OSTEOPOROSIS
    Sosunova, N. V.
    Belaya, Z. E.
    Dzeranova, L. K.
    Mokrysheva, N. G.
    Rozhinskaya, L. Y.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 158 - 159
  • [27] Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
    Min, Yong-Ki
    ENDOCRINOLOGY AND METABOLISM, 2015, 30 (01) : 19 - 26
  • [28] Risedronate for prevention and treatment of osteoporosis in postmenopausal women
    Recker, RR
    Barger-Lux, J
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (03) : 465 - 477
  • [29] Combination and sequential treatment in women with postmenopausal osteoporosis
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Yavropoulou, Maria P.
    Makras, Polyzois
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (04) : 477 - 490
  • [30] Cyclical alendronate treatment in postmenopausal women with osteoporosis
    Kösüs, A
    Çapar, M
    Kösüs, N
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (02) : 182 - 184
12345